SARCOMA - Cancer proteome, tumor vs adjacent non-tumor (ProteinTalks DB, GIST)
Number of samples
50 (25 tumor / adjacent non-tumor pairs)
Detected in
25/25 tumors, 25/25 non-tumors
Tumor vs non-tumor
Down in tumor (log2FC -0.84, adj. p-value 8.71e-4)
Samples
Patient ID
Tumor
Non-tumor
GIST_01
17.6
16.6
GIST_07
16.1
14.1
GIST_22
15.8
16.1
GIST_20
15.7
15.8
GIST_19
15.7
15.7
GIST_09
15.6
16.8
GIST_13
15.6
16.3
GIST_06
15.6
16.4
GIST_05
15.5
17.0
GIST_04
15.5
17.5
GIST_14
15.5
16.8
GIST_03
15.5
16.8
GIST_25
15.4
15.5
GIST_21
15.4
16.4
GIST_16
15.3
16.2
GIST_18
15.3
16.8
GIST_15
15.1
16.4
GIST_08
15.1
15.3
GIST_10
15.0
16.2
GIST_17
14.9
16.4
GIST_12
14.9
16.3
GIST_11
14.9
15.5
GIST_02
14.9
16.2
GIST_23
14.8
16.9
GIST_24
14.5
15.9
Show allShow less
SARCOMA - Cancer proteome, tumor vs adjacent non-tumor (ProteinTalks DB, MUT)
Number of samples
48 (24 tumor / adjacent non-tumor pairs)
Detected in
24/24 tumors, 24/24 non-tumors
Tumor vs non-tumor
Not significant (log2FC -0.06, adj. p-value 8.93e-1)
Samples
Patient ID
Tumor
Non-tumor
MUT_14
17.5
15.4
MUT_13
17.5
16.0
MUT_07
17.0
15.9
MUT_12
16.9
17.0
MUT_15
16.7
16.9
MUT_02
16.6
16.5
MUT_10
16.6
16.9
MUT_01
16.5
16.2
MUT_04
16.4
16.7
MUT_17
16.4
16.2
MUT_23
16.3
16.6
MUT_03
16.2
16.4
MUT_21
16.2
16.1
MUT_19
16.1
16.7
MUT_16
16.1
16.5
MUT_20
16.1
15.9
MUT_06
16.0
17.4
MUT_18
15.8
15.7
MUT_24
15.7
15.9
MUT_22
15.7
15.3
MUT_05
15.6
15.5
MUT_09
15.4
16.0
MUT_08
15.2
16.5
MUT_11
14.0
15.8
Show allShow less
We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.